Comparison of fluconazole and amphotericin B in prophylaxis of experimental Candida endocarditis caused by non-C. albicans strains

Antimicrobial Agents and Chemotherapy

Volumn 40, Issue 2, 1996, Pages 494-496

  Bayer, Arnold S ^a,b,c   Witt, Mallory D ^a,b,c   Kim, Eric ^a,b   Ghannoum, Mahmoud A ^a,b,c  

^a HARBOR UCLA MEDICAL CENTER   (United States)

^b St John's Cardiovascular Research Center   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; FLUCONAZOLE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANDIDA PARAPSILOSIS; CANDIDA TROPICALIS; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; ENDOCARDITIS; HEART VALVE PROSTHESIS; INDWELLING CATHETER; INTRAPERITONEAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MYCOSIS; NONHUMAN; PRIORITY JOURNAL;

EID: 0030025639     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.40.2.494     Document Type: Article

References (29)

1. Bayer, A. S., D. C. Norman, C. Y. Chiu, and C. C. Nast. 1989. Pathogenetic effects of neutropenia, monocytopenia and steroid treatment in experimental Pseudomonas endocarditis. Chemotherapy (Basel) 35:278-288.
2. Bayer, A. S., and J. Tu. 1990. Chemoprophylactic efficacy against experimental endocarditis caused by β-lactamase-producing, aminoglycoside-resistant enterococci is associated with prolonged serum inhibitory activity. Antimicrob Agents Chemother. 34:1068-1074.
3. Berney, P., and P. Francioli. 1990. Successful prophylaxis of experimental streptococcal endocarditis with single-dose amoxicillin administered after bacterial challenge. J. Infect. Dis. 161:281-285.
4. Como, J. A., and W. E. Dismukes. 1994. Oral azole drugs as systemic antifungal therapy. N. Engl. J. Med. 33:264-272.
5. Dajani, A. S., A. L. Bisno, D. T. Chung, et al. 1990. Prevention of bacterial endocarditis - recommendations by the American Heart Association. JAMA 246:2919-2922.
6. DeMuria, D., A. Forrest, J. Rich, J. M. Scavone, L. G. Cohen, and P. H. Kazanjian. 1993. Pharmacokinetics and bioavailability of fluconazole in patients with AIDS. Antimicrob. Agents Chemother. 37:2187-2192.
7. Doscher, W., K. V. Krishnasatry, and S. L. Deckoff. 1987. Fungal graft infections; case report and review of the literature. J. Vasc. Surg. 6:398-402.
8. Fluckiger, U., P. Francioli, J. Blaser, M. P. Glauser, and P. Moreillon. 1994. Role of amoxicillin serum levels for successful prophylaxis of experimental endocarditis due to tolerant streptococci. J. Infect. Dis. 169:1397-1400.
9. Gallis, H. A., R. H. Drew, and W. W. Pickard. 1990. Amphotericin B: 30 years of clinical experience. Rev. Infect. Dis. 12:308-329.
10. 9a. Ghannoum, M. A. Unpublished data.
11. Glauser, M. P., P. Bernard, P. Moreillon, and P. Francioli. 1983. Successful single-dose amoxicillin prophylaxis against experimental streptococcal endocarditis: evidence for two mechanisms of protection. J. Infect. Dis. 147: 568-575.
12. Goodman, J. L., D. J. Winston, R. A. Greenfield, P. H. Chandrasekar, B. Fox, H. Kaizer, et al. 1992 A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation. N. Engl J. Med. 326:845-851.
13. Harvey, R. L., and J. P. Meyers. 1987. Nosocomial fungemia in a large community teaching hospital. Arch. Intern. Med. 147:2117-2120.
14. Konshian, S. V., A. K. Uwaydah, J. D. Sobel, and L. R. Crane. 1989. Fungemia due to Candida species and Torulopsis glabrara in the hospitalized patient: frequency, characteristics and evaluation of factors influencing outcome. Rev. Infect Dis. 11:379-390.
15. Moyer, D. V., and J. E. Edwards, Jr. 1992. Fungal endocarditis, p. 299-312. In D. Kaye (ed.), Infective endocarditis, 2nd ed. Raven Press, New York
16. Powderly, W., D. M. Finkelstein, J. Feinberg, P. Frame, H. Weili, C. van der Horst, et al. 1995 A randomized trial comparing fluconazole with clotrimazole troches in the prevention of fungal infections in patients with advanced human immunodeficiency virus infection. N. Engl. J. Med. 332:700-705.
17. Rangel-Frausto, M. S., M. A. Martin, L. Saiman, H. Blumberg, J. E. Paterson, M. A. Pfaller, R. P. Wenzel, and the NEMIS Study Group. 1994. High-prevalence of Candida spp. on hands of health care workers (HCWs) in surgical (S) and neonatal (N) intensive care units (ICUs): a multicenter study, abstr. J106, p. 105 In Proceedings of the 34th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
18. Rex, J. H., J. E. Bennett, A. M. Sugar, P. G. Pappas, C. M. van der Horst, J. E. Edwards, Jr., et al. 1994. A randomized trial comparing fluconazole with amphotericin B for the treatment of candidemia in patients without neutropenia. N. Engl. J. Med. 331:1325-1330.
19. Rotrosen, D., R. Calderone, and J. E. Edwards, Jr. 1986. Adherence of Candida species to host tissues and plastic surfaces Rev. Infect Dis. 8:73-85
20. Rotrosen, D., T. R. Gibson, and J. E. Edwards, Jr. 1983. Adherence of Candida species to intravenous catheters. J. Infect. Dis. 147:594.
21. Saag, M., and W. E. Dismukes. 1988. Azole antifungal agents: emphasis on new triazoles. Antimicrob. Agents Chemother. 32:1-8.
22. Sanchez, V., J. A. Vazquez, D. Barth-Jones, L. Dembry, J. D. Sobel, and M. J. Zervos. 1993. Nosocomial acquisition of Candida parapsilosis: an epidemiologic study. Am. J. Med. 94:577-582.
23. Stevens, D. A., S. I. Greene, and O. S. Lang. 1991. Thrush can be prevented in patients with acquired immunodeficiency syndrome and the acquired immunodeficiency syndrome-related complex - randomized, double-blind, placebo-controlled study of 100 mg oral fluconazole daily. Arch. Intern. Med. 151:2458-2464.
24. Walsh, R. J., and P. A. Pizzo. 1988 Treatment of systemic fungal infections: recent progress and current problems. Eur. J. Clin. Microbiol. Infect. Dis. 7: 460-475.
25. Wey, S. B., M. Mori, M. A. Pfaller, R. F. Woolson, and R. P. Wenzel. 1988. Hospital-acquired candidemia: the attributable mortality and excess length of stay. Arch. Intern. Med. 148:2642-2645.
26. Wingard, J. R., W. G. Merz, and R. Saral. 1979. Candida tropicalis: a major pathogen in immunocompromised patients. Ann. Intern. Med. 91:539-543.
27. Winston, D. J., P. H. Chandresekar, H. M. Lazarus, J. L. Goodman, J. L. Silber, H. Horowitz, et al. 1993. Fluconazole prophylaxis of fungal infections in patients with acute leukemia: results of a, randomized, placebo-controlled, double-blind, multicenter trial Ann. Intern. Med. 118:495-503.
28. Witt, M. D., and A. S. Bayer. 1991. Comparison of fluconazole and amphotericin B for prevention and treatment of experimental Candida endocarditis. Antimicrob. Agents Chemother. 35:2481-2485.
29. Witt, M. D., T. Imhoff, C. Li, and A. S. Bayer. 1993. Comparison of fluconazole and amphotericin B for treatment of experimental Candida endocarditis caused by non-C. albicans strains. Antimicrob. Agents Chemother. 37: 2030-2032